Patent Assignment
Reel/Frame 062780/0143
Assignment of Assignor's Interest
Recorded: 2023-02-23
Pages: 5
Assignor
CELLULAR BIOMEDICINE GROUP HK LIMITED
Executed: 2022-12-12
Assignee
CELLULAR BIOMEDICINE GROUP, INC.
9605 MEDICAL CENTER DRIVE, SUITE 100, ROCKVILLE, MARYLAND, 20850
Covered Property
(1)
Construction of Chimeric Antigen Receptor Targeting CD20 Antigen and Activity Identification of Engineered T Cells Thereof
Application:
18/173,187 →
Publication:
US 2023/0242613
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 23, 2023
From: YAO, YIHONG; HUANG, JIAQI; ZHU, SHIGUI; ZHU, WEI
To: CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.; CELLULAR BIOMEDICINE GROUP (WUXI) LTD.
Reel/Frame 062779/0784 →
Assignment of Assignor's Interest
Feb 23, 2023
From: CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 062779/0928 →
Assignment of Assignor's Interest
Feb 23, 2023
From: CELLULAR BIOMEDICINE GROUP (WUXI) LTD.
To: CELLULAR BIOMEDICINE GROUP HK LIMITED
Reel/Frame 062780/0017 →
Change of Name
Jan 19, 2024
From: CELLULAR BIOMEDICINE GROUP, INC.
To: ABELZETA INC.
Reel/Frame 066356/0108 →